US2004198776A1PendingUtilityA1

Methods for increasing leptin levels using nicotinic acid compounds

Assignee: JACCOBSON ELAINEPriority: Mar 8, 2001Filed: Apr 14, 2004Published: Oct 7, 2004
Est. expiryMar 8, 2021(expired)· nominal 20-yr term from priority
A61P 43/00A61P 3/04A61P 35/00A61K 31/455A61P 17/14A61P 17/02A61P 17/00
44
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to the use of nicotinic acid and nicotinic acid esters, such as nicotinic acid alkyl esters, to increase the amount of leptin in a subject. As a result, one can treat conditions, such as conditions characterized by wounds, by administering sufficient amounts of nicotinic acid or nicotinic acid ester to increase leptin levels to alleviating amounts. Various conditions and modes of treatment are disclosed.

Claims

exact text as granted — not AI-modified
1 - 12 . (Cancelled)  
     
     
         13 . A method for increasing leptin levels in a subject in need of improved immune function, skin epitheliation, hair follicle cycling, or inhibition of tumor formation, comprising administering to said subject an amount of nicotinic alkyl ester sufficient to increase leptin levels in said subject and improve immune function, improve skin epitheliation, improve hair follicle cycling, or inhibit tumor formation, wherein the alkyl chain of said nicotinic acid alkyl ester contains from 8 to 22 carbon atoms.  
     
     
         14 . The method of  claim 13 , wherein said subject is in need of improved immune function.  
     
     
         15 . the method of  claim 13 , wherein said subject is in need of improved skin epitheliation.  
     
     
         16 . The method of  claim 13 , wherein said subject is in need of improved hair follicle cycling.  
     
     
         17 . The method of  claim 13 , wherein said subject is in need of inhibition of tumor formation.  
     
     
         18 . The method of  claim 13 , wherein said alkyl chain contains 12 or 14 carbon atoms.  
     
     
         19 . The method of  claim 13 , wherein said nicotinic acid alkyl ester is administered orally.  
     
     
         20 . The method of  claim 13 , wherein said nicotinic acid alkyl ester is administered topically.  
     
     
         21 . The method of  claim 13 , comprising administering more than one nicotinic acid alkyl ester.

Join the waitlist — get patent alerts

Track US2004198776A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.